Sterilization Validation and Packaging Requirements for Iran Registration

1. Key takeaways

Sterile devices submitted in Iran require complete sterilization validation and sterile barrier system evidence; the core standards are ISO 11135 (ethylene oxide), ISO 11137 (radiation) and ISO 11607 (packaging). The judgement of GRZAN is that the common defect in this module is not “no report” but three parameters in the reports that do not match the actual product — the sterilization method, the sterility assurance level (SAL) and the shelf life must be mutually consistent. The three parameters appear in separate documents, but reviewers read them as a single claim about one product. One self-consistent story, told across three documents, is the pass condition.

• Sterile devices need complete sterilization validation and sterile barrier system evidence for submission in Iran. Incomplete evidence in this module is treated as a substantive gap, not a formatting one.
• The core standards are ISO 11135, ISO 11137 and ISO 11607.
• The typical defect is not a missing report but a report whose parameters do not match the product as actually supplied.
• Sterilization method, SAL and shelf life must form one self-consistent set, verified across the dossier. Any change to one parameter is a change to the product, and the dossier must show the chain re-validated.

2. Legal basis

The legal and normative references supporting this module are the following.

1. ISO 11135 (ethylene oxide sterilization), ISO 11137 (radiation sterilization) and ISO 11607 (packaging for terminally sterilized medical devices): generally accepted by the Iranian authorities; where a corresponding ISIRI standard exists, conformity is judged against the ISIRI standard — this is a practical estimate.
2. Sterility assurance level: terminally sterilized devices are usually validated against a SAL of 10⁻⁶ — this is a practical estimate; the standard applicable to the product prevails.
3. Law on the Administration of Medical, Pharmaceutical and Food-Beverage Affairs, FAOLEX LEX-FAOC227692, 1955-06-20, Article 3.

3. Expert insights

Insight 1: three-parameter consistency is checked again and again. The sterilization method determines the validation approach; the validation approach determines whether the SAL can be achieved; and the packaging system determines whether the claimed shelf life can be maintained. The three parameters are not independent facts about the product — they are a chain, and a change at any link forces the other two to be re-argued. Reviewers therefore return to this point repeatedly, cross-checking the method against the validation, the validation against the SAL and the packaging against the shelf life. The most common failure GRZAN sees is a company that changed its packaging supplier, forgot that the change invalidated the existing validation, and submitted a dossier whose shelf life claim no longer had a validation standing behind it. Building the check sheet early makes the inconsistency visible inside the team before it is visible to a reviewer, which is the cheaper side of the discovery. Consistency across the three parameters is also the fastest thing for a reviewer to check, which is why it is checked so often.

Insight 2: packaging validation must cover transport. Part 2 of ISO 11607 addresses seal integrity and packaging process validation, and a validation that ends at the factory gate leaves the hardest question unanswered. These are the two places where a package fails quietly, without anyone noticing until the product is already in the field. Iran’s transport conditions — high temperatures and long distances — put real stress on sterile barriers, which makes validation of packaging integrity after transport far more persuasive than validation under laboratory conditions alone. A validation plan that models the actual journey, including the thermal load it imposes on the package, demonstrates that the sterile barrier survives the route the product will actually take. A plan that ignores the route leaves the reviewer to assume the worst about it. Designing the transport simulation around the real route, including the conditions it imposes on the package, is what gives the result its weight.

Insight 3: the division of responsibility for outsourced sterilization must be written down. Sterilization is frequently outsourced, and outsourcing is legitimate — but it moves a critical process outside the walls of the manufacturer, which makes the contractual arrangements part of the compliance evidence. Where the sterilization step is performed by a provider, the qualifications of that provider and a quality agreement between the two parties are required, making the boundary of responsibility explicit: who owns the validation, who owns the routine controls, who is notified when something changes. An undocumented arrangement leaves both parties nominally responsible and therefore neither one accountable, which is precisely what a reviewer cannot accept. Outsourcing the step does not outsource the accountability. The agreement should also state how changes on either side are communicated, because a silent change at the provider breaks the chain as effectively as a silent change at the manufacturer.

4. Practical recommendations

• Build a three-parameter consistency check sheet: cross-check the sterilization method, the SAL and the shelf life against each other. A short table catches what a long review catches, earlier.
• Redo validation after packaging changes: any change of packaging material or supplier triggers revalidation. Revalidation is triggered, not negotiated.
• Validate packaging integrity after transport: design the validation plan around Iran’s actual transport conditions, modelling the journey the product will actually take.
• Prepare complete quality agreements for outsourced sterilization: provide the provider’s qualifications and the bilateral quality agreement, so the reviewer can see the boundary of responsibility in writing.

5. Verification checklist

• □ The three parameters — sterilization method, SAL and shelf life — have been cross-checked and are self-consistent
• □ ISO 11135/11137 validation reports have been submitted and are within their validity period
• □ ISO 11607 packaging validation covers seal integrity and post-transport integrity
• □ Packaging changes have triggered revalidation
• □ The sterilization provider’s qualifications and the quality agreement are complete

Regulatory information verified as of October 29, 2026

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Iranian market. Our team prepares IFDA-compliant dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com